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We used homologous recombination in embryonic stem cells to generate mice heterozygous for an aryl hydrocarbon nuclear
translocator (ARNT) null mutation. These mice were intercrossed, but no live homozygous Arnt 0/0 knockout mice were
produced among 64 newborns. Homozygotes die in utero between 9.5 and 10.5 days of gestation. Abnormalities included
neural tube closure defects, forebrain hypoplasia, delayed rotation of the embryo, placental hemorrhaging, and visceral
arch abnormalities. However, the primary cause of lethality appears to be failure of the embryonic component of the
placenta to vascularize and form the labyrinthine spongiotrophoblast. This may be related to ARNT's known role in
hypoxic induction of angiogenesis. We found no defects in yolk sac circulation. q 1997 Academic Press
INTRODUCTION 1a), which as a dimer with ARNT is involved in mediating
cellular responses to hypoxia (Wang and Semenza, 1995)
including increased expression of vascular endothelialThe aryl hydrocarbon nuclear translocator protein
(ARNT) is a founding member of the basic helix±loop± growth factor (VEGF; Wood et al., 1996); and endothelial
PAS domain protein 1 (EPAS1/HLF), which appears to be ahelix/ Per±ARNT±Sim (bHLH/PAS) family of transcription
factors. The basic motif of these proteins is involved in regulator of embryonic vascularization with activation of
EPAS1 being stimulated by hypoxic conditions (Tian et al.,sequence-dependent recognition of DNA, while the PAS
domain acts in concert with the bHLH domain to form a 1997; Ema et al., 1997). As a step toward elucidating the
physiological function of ARNT in the whole organism, wedimerization surface (Reisz-Porszasz et al., 1994; Fukunaga
et al., 1995). We and others have demonstrated that ARNT generated and analyzed Arnt-de®cient transgenic mice.
interacts with several other members of the bHLH/PAS
family. These include the aryl hydrocarbon receptor, which
after binding ligand dimerizes with ARNT and activates MATERIALS AND METHODS
transcription of a number of target genes, including
CYP1A1, the products of which are involved in the metabo- Generation of Mice Heterozygous for an Arnt Null
lism of aryl hydrocarbons to toxic or carcinogenic interme- Allele
diates (reviewed by Hankinson, 1995); SIM-1 (single-minded
1) and SIM-2, which may be involved in developmental reg- A genomic library developed from the 129/SvJ mouse strain (Stra-
tagene) was probed with a PCR-ampli®ed (650 bp) fragment ofulation of the mouse central nervous system (Ema et al.,
mouse Arnt cDNA encompassing the bHLH domain, and a 6-kb1996; Probst et al., 1997); hypoxia-inducible factor 1a (HIF-
Arnt genomic fragment was isolated. The segment of the mouse
Arnt gene encoding the bHLH region is contained within a single
exon, corresponding to amino acids 92 to 162. A targeting plasmid1 To whom correspondence should be addressed at Department
of Pathology and Laboratory Medicine, University of California, was constructed (Fig. 1A) that included the 6-kb Arnt fragment
with the bHLH domain interrupted by insertion of a neomycinLos Angeles Medical Center, Center for the Health Sciences, Los
Angeles, CA 90095-1732. Fax: (310) 794-9272; E-mail: ohank@ phosphotransferase cassette (pMC1neopA; Thomas and Capecchi,
1987), and ¯anked on either side by a herpes simplex thymidinepathology.medsch.ucla.edu.
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FIG. 1. (A) Targeting strategy. The wild-type allele, the targeting vector and the mutant allele are shown. The pMC1±neomycin resistance
cassette and pMC1±thymidine kinase cassette are designated as NEO and TK, respectively. Arrows show the orientation of the genes.
Restriction enzyme sites used for cloning and Southern blot analysis are indicated (B, BstEII; E, EcoRI; K, KpnI). The double-arrow lines
indicate the sizes of restriction fragments hybridizing to the probes used for Southern blot analysis. (B) Southern blot analysis of EcoRI-
digested genomic DNA prepared from neomycin- and FIAU-resistant ES cell clones hybridized to the probes indicated in A (data for clones
76 and 109 shown). The size for the EcoRI fragment associated with the ES cell wild-type allele hybridized with either the bHLH or 130-
bp probe is 7 kb, while no fragment is identi®ed with the neo probe. The targeted allele, due to insertion of 1.1 kb and addition of an
EcoRI site, resulted in EcoRI fragments of 7.6 kb for all probes (a faint 0.6-kb fragment was also observed with the bHLH probe, as
expected). Proper insertion was also demonstrated by digestion with BstEII and KpnI (data not shown). No additional hybridization bands
were observed in clone 76 or 109, indicating that there were no nonhomologous insertions. Clones 76 and 109, isolated from independent
electroporations, were used to generate chimeric mice which were then mated to C57BL/6J females. (C) Identi®cation of heterozygous
progeny. Tail DNA of light chinchilla offspring from male chimeras derived from clone 109 mated with C57BL/6J females were digested
with KpnI and hybridized to the bHLH probe. In /// light chinchilla progeny, the bHLH probe recognized ES cell (129/SvJ) wild-type
genomic DNA fragments of 4.5 and 15 kb and C57BL/6J wild-type genomic DNA fragments of 15 and 16.5 kb. In //0 light chinchilla
progeny, the bHLH probe recognized C57BL/6J wild-type genomic DNA fragments of 15 and 16.5 kb and an ES cell-derived (129/SvJ)
targeted fragment of 20.6 kb. The size difference of the wild-type bands is due to polymorphism between 129/Sv and C57BL/6. (D) Southern
blot analysis of KpnI-digested DNA isolated from embryo or yolk sac derived from progeny of heterozygous intercrosses probed with the
bHLH probe. (E) PCR analysis of individual, day 9.5 embryonic DNA isolated from progeny of heterozygous intercrosses with one forward
and two reverse primers used simultaneously (af, ar, nr) to detect the targeted Arnt allele and the wild-type Arnt allele. The Arnt forward
and reverse pair ampli®es a 150-bp wild-type band and the Arnt forward and neo reverse pair ampli®es a 250-bp recombinant band. (F)
Western blot analysis of ARNT expression. Western blot analysis was performed using af®nity-puri®ed rabbit±ARNT antiserum directed
against the carboxy terminus half of the ARNT protein as described previously (Probst et al., 1993) and developed using the SuperSignal
ULTRA chemiluminescent substrate (Pierce). Extracts (50 mg of protein) from embryonic tissue isolated from ///, //0, and 0/0 GD
9.5 embryos were applied on 7.5% SDS±PAGE.
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kinase (HSV-tk) expression cassette (pMC1tk pA). The neo cassette dase (Vector Labs, Burlingame, CA). Feulgen stain of the yolk sac
was performed by microinjecting Feulgen into the chorionic spacewas inserted into a unique KpnI site in the Arnt DNA fragment
giving rise to one Arnt arm of approximately 1.3 kb and the other immediately after collection of the conceptus, before opening the
extraembryonic membranes. Embryos of similar developmentalof about 4.7 kb. The KpnI site was destroyed in the ligation and an
EcoRI site was introduced. The transcriptional orientation of the stages as determined by somite numbers were chosen for our com-
parison studies in order to rule out any differences resulting fromneomycin-resistance gene was opposite to that of the Arnt gene. A
null mutation was expected because the reverse orientation of the developmental delay or arrest (e.g., developmentally retarded em-
bryos may have immature yolk sacs and placenta).neo cassette contains multiple stop codons in each reading frame.
If exon skipping did occur, it would delete the bHLH domain re- A simple regression model was used to compare dead/resorbed
or developmentally delayed/abnormal embryos to gestation day.quired for dimerization and DNA binding and any resultant protein
would be nonfunctional. For statistical analysis of somite number and embryo size within
a gestation day, an analysis of variance was performed. A mixedThe targeting vector was linearized at a unique HindIII site in
the bacterial backbone and electroporated into 129/SvJ germline effects linear model was used to associate size with somite number
between genotypes. A Pearson x2 analysis was performed on geno-competent RW4 ES cells (Genome Systems). Electroporated embry-
onic stem (ES) cells were plated onto a monolayer of g-irradiated, type ratios.
neomycin-resistant mouse primary ®broblasts and were grown in
the presence of LIF (1000 u/ml, GIBCO-BRL). Putative homologous
recombinants were identi®ed by selection of resistant colonies in
250 mg/ml G418 (geneticin; GIBCO-BRL) and 0.2 mM FIAU (1-[2- RESULTS
deoxy, 2-¯uoro-b-D-arabinofuranosyl]-5-iodouracil), added after 24
h, and maintained for 10 days (positive±negative selection, Man-
Generation of Mice Heterozygous for an Arnt Nullsour et al., 1988). To con®rm single integration events and homolo-
Mutationgous recombination of the targeting construct, each clone was ana-
lyzed by Southern blot of genomic DNA using the following probes: An Arnt-targeting vector was transfected into ES cells and
(1) a 190-bp bHLH-speci®c probe spanning the disrupted KpnI site,
putative homologous recombinants isolated by selection in(2) a 130-bp Arnt-speci®c probe external to the region found in the
geneticin (G418) and FIAU. Southern blot analysis of 131construct, identifying only true homologous recombination events,
clones detected 3 in which one Arnt allele was disrupted byand (3) a 300-bp neo-speci®c probe identifying all integration
homologous recombination and in which no other plasmidevents, including random events (Fig. 1B).
integration events had occurred (Figs. 1A and 1B). TwoTwo correctly targeted 129/SvJ ES cells were microinjected into
C57BL/6J blastocysts isolated at day 3.5 (Bradley, 1987). The blasto- clones were injected into C57BL/6J blastocysts and chime-
cysts were introduced into pseudopregnant females and chimeric ric mice were generated. Both clones gave several male chi-
males among the resulting progeny were mated to C57BL/6J fe- meras with ES coat color contribution greater than 80%.
males. Light chinchilla progeny were genotyped and Arnt heterozy- Light chinchilla progeny (F1) were genotyped by Southern
gosity identi®ed by Southern analysis of tail DNA. Mice heterozy- analysis of tail DNA (Fig.1C). Only clone 109 transmitted
gous for the targeted mutation were then intercrossed to obtain
the ES cells through the germline when chimeras weremice homozygous for the disrupted Arnt null allele.
mated with C57BL/6J females. Of the ®ve male chimeras
generated from clone 109, three of them transmitted the
mutant allele to offspring, yielding Arnt (//0) heterozy-Genotyping Mice and Embryos
gotes.
Genotyping of adult mice was performed by Southern blot analy-
sis of digested tail DNA. The genotypes of dissected embryos were
determined by Southern blot analysis or PCR using DNA isolated Lethality of Arnt 0/0 Mice in Uterofrom yolk sac or embryo. The PCR primers corresponded to the
bHLH domain (Arnt forward [af], 5*-CATAGTGAAATAGAACGG- Mice heterozygous for the targeted mutation were inter-
CGGCG-3*; Arnt reverse [ar], 5*-AGGACTTCATGTGAGAAA- crossed, but no live homozygous Arnt 0/0 mice were pro-
CGGC-3*) and the neo gene (neo reverse [nr], 5*-TGGCGGCGA-
duced among 64 neonates from 14 litters. Pregnant femalesATGGGCTGACC-3*).
from Arnt //0 intercrosses were sacri®ced at different
times of gestation, and 0/0 mutants were identi®ed by
Southern blotting (Fig. 1D) and/or PCR (Fig. 1E). ResultsAnalysis of Embryos
demonstrated that most homozygous embryos die between
Embryos were harvested from matings between heterozygotes GD 9.5 and 10.5. The distribution of genotypes in GD 8.5
for the Arnt mutation between gestation day (GD) 7.5 and 17.5. to 10.5 embryos (dead or alive) from 17 heterozygous mat-
Expression of ARNT was determined in the GD 9.5 conceptus by ings was 32:70:24 (///, //0, and 0/0, respectively) and is
immunostaining (Abbott and Probst, 1995). Sections of all three not statistically different from the expected ratio of 1:2:1.
genotypes (///,//0, 0/0) were processed on a single slide. Vascu-
From GD 11.5 to 17.5 and postnatally, all viable pups werelogenesis and angiogenesis were assessed by PECAM immunostain-
either/// or//0 (36 and 59, respectively) and this distribu-ing of endothelial cells using a puri®ed anti-mouse CD31 (Phar-
tion does not differ signi®cantly from a 1:2 ratio. Thus noMingen; San Diego, CA; diluted 1:1000) and detected with biotin
evidence for embryonic lethality of the Arnt //0 heterozy-conjugated anti-rat Af®niPure antibody (Jackson Immunoresearch
Laboratories, West Grove, PA) and the Vector ABC Kit for peroxi- gote was obtained.
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Expression of ARNT in the Conceptus which was associated with visceral arch abnormalities, as
re¯ected in decreased head length for 0/0 embryos (Ta-ARNT protein expression in the embryos was analyzed
ble 1).by Western blotting (Fig. 1F). The level of ARNT was ap-
proximately twofold greater in /// embryos than in //0
embryos and was undetectable in 0/0 embryos (Fig. 1E). Defective Placental Vascularization in 0/0 Mice
Extensive expression of ARNT was detectable by immuno-
histochemical analysis throughout the GD 9.5 Arnt /// At GD 9±9.5 the embryonic portion of the placenta forms
and Arnt //0 embryos, while no expression was detectable a primitive allantoic vasculature, while the maternal de-
in Arnt 0/0 embryos (data not shown). The knockout con- cidua develops numerous blood-®lled clefts. It is at this
ceptus also showed no expression of ARNT protein in the time that the endothelial cell-lined allantoic cavities con-
placental cells derived from the embryo, although adjacent tain nucleated embryonic blood cells and the primitive pla-
maternal decidual cells express ARNT (Figs. 2B and 2F). In centa begins to supply nutrients and oxygen to the embryo.
the /// and //0 placenta, ARNT is expressed in nuclei of We therefore examined vascularization of the placenta by
the maternal decidual cells, in embryonic trophoblasts, and immunostaining with antibody to platelet endothelial cell
in the single layer of trophoblast giant cells which sur- adhesion molecule (PECAM; Figs. 2C and 2D). In Arnt
rounds the embryo and lies between the maternal and em- knockout embryos the allantois extends across the exocoe-
bryonic placental regions (Figs. 2A and 2E). lomic cavity and fuses with the chorionic plate. However,
the subsequent formation of an extensive endothelial cell-
lined vascular network was not observed (Fig. 2D). In con-Developmental Delay and Growth Retardation in trast, the /// and //0 placenta do not differ morphologi-0/0 Embryos cally from each other and both form the labyrinth and spon-
giotrophoblastic layers with abundant endothelial cell-linedOn GD 8.5 the 0/0 embryos were not distinguishable
from littermates by developmental stage as indicated by vascular networks (Fig. 2C; //0 data not shown). Thus, the
embryonic component of the placenta of the0/0 conceptussomite number (Table 1). Observation of heartbeat and
blood circulation in the yolk sac vasculature and in the was small with fewer PECAM-stained endothelial cell-lined
cavities than with the/// or//0 conceptuses. Upon exam-embryo indicated that GD 8.5 embryos were viable and that
vasculogenesis was proceeding normally in //0 and 0/0 ination of gross morphology, all 0/0 GD 9.5 placentas had
small chorioallantoic plates in combination with fewer lab-embryos. On GD 9.5, the 0/0 embryos were at a develop-
mental stage similar to that of /// embryos because there yrinthine cavities, indicating that the placental region is
not differentiating as expected.was no signi®cant difference in somite numbers (Table 1),
but most knockout embryos were growth retarded as indi- Observation of yolk sacs at dissection revealed that an
extensive vascular plexus forms and that circulation existscated by signi®cant decreases in crown rump and head
length. By GD 10.5, the embryos were developmentally de- in the major vessels of all genotypes. In sections, the devel-
opment of the yolk sac in the knockout embryos was similarlayed with signi®cantly decreased somite number. The
number of 0/0 embryos showing an abnormal phenotype to that observed for the /// embryos. The yolk sacs of all
genotypes were vascularized with blood cells in the vesselsand/or developmental delay was 60% at GD 9.5 and 100%
by GD 10.5. Among 15 0/0 embryos from 10 litters at GD (Figs. 3A±3G). Vascularization of the yolk sac was also ex-
amined in whole-mount Feulgen-stained preparations, and9.5, 20% showed delayed rotation, 40% showed placental
hemorrhaging, and 40% showed unfused head folds. The 0/0 yolk sac (Figs. 3E and 3G) showed major vessels as well
as the ®ne vessel mesh present in the //0 (Fig. 3F) and //severity of neural tube defects ranged from open anterior
or posterior neuropore, small open region in the mid- or / tissue (data not shown). PECAM staining (Figs. 3C and
3D) showed endothelial cell-lined blood vessels for both //hindbrain, to complete failure of the head folds to close
(Figs. 4A and 4B). We also observed forebrain hypoplasia / and 0/0 embryonic yolk sacs. The separation of adjacent
FIG. 2. (A±F) Placenta of GD 9.5 conceptus. (A,B) Expression of ARNT protein. (A) The placenta of the /// conceptus showed expression
of ARNT in maternal and embryonic compartments and was in the process of vascularization in the spongiotrophoblast and chorioallantoic
regions. (B) In contrast, the placenta of the 0/0 conceptus was small with minimal vascularization and ARNT was not expressed in the
embryonic region. (A and B lightly counterstained with hematoxylin). (C,D) Formation of the chorionic labyrinth and spongiotrophoblastic
layer revealed through PECAM staining of endothelial cells. (C) PECAM staining demonstrated the complexity of the vascular network
of endothelial-cell lined cavities (arrows) in the /// placenta. (D) The 0/0 placenta exhibited a few large endothelial-cell-lined cavities
(arrows). (E,F) ARNT expression at the maternal±fetal border. (E) ARNT was expressed in maternal and embryonic tissues in the ///
conceptus with trophoblast giant cells having high levels. (F) ARNT expression was observed in the maternal decidua (d) of the 0/0
conceptus; however, in the cells of embryonic origin, including the trophoblast giant cells, ARNT expression was eliminated by the gene
knockout. (Bar, 100 mm; b, endogenous peroxidase in blood cells; c, chorionic plate; d, maternal decidual placenta; e, embryonic placental
tissue; g, trophoblast giant cells; s, spongiotrophoblast; y, yolk sac).
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TABLE 1 (Maltepe et al., 1997), and who postulated that lethality was
Effects of Genotype on Growth and Development due to insuf®cient vascularization of the yolk sac and solid
tissues. The Arnt knockout of Maltepe and co-workers was
Gestation day readily distinguished from heterozygous or wild-type lit-
termates on GD 9.5 by an absence of blood-®lled yolk sac8.5 9.5 10.5
vessels. Our Arnt knockout embryos cannot be distin-
n, somites /// 6.7 { 0.9 17.2 { 1.5 33.8 { 2.9 guished from littermates on this basis because all embryos
//0 9.3 { 0.5 21.0 { 1.2* 26.9 { 1.1 exhibited equivalent development of the yolk sac circula-
0/0 6.3 { 1.5 16.7 { 2.0² 16.0 { 4.0*,² tion (Figs. 3E±3G). In our case, circulation of blood cells was
Crown /// ND 3.1 { 0.2a 4.9 { 0.4 observed in large vitelline vessels and through the vascular
Rump //0 ND 3.1 { 0.1a 3.9 { 0.3 capillary mesh in all genotypes on GD 9.5. The GD 9.5 0/
Length (mm) 0/0 ND 2.0 { 0.2a,*,² 3.3 { 0.5*,² 0 embryos of Maltepe and co-workers were described asHead /// ND 1.3 { 0.1 2.7 { 0.3
``smaller and generally wasted, and development was de-Length //0 ND 1.4 { 0.1 2.1 { 0.2
layed.'' Based on this statement, their embryos are in worse(mm) 0/0 ND 1.0 { 0.1*,² 1.6 { 0.2*,²
condition on GD 9.5 and appear to be dying somewhat ear-
Note. Data from 4, 10, and 5 litters; GD8.5, 9.5, and 10.5, respec- lier than our embryos. Our Arnt 0/0 embryos on GD 9.5
tively. do not show developmental delay (somite numbers are not
a Measured from ®xed tissues. signi®cantly different between genotypes) and are not de-
* P  0.05 vs ///; ² vs //0. generating at that age.
The later death of our Arnt 0/0 embryos correlates with
insuf®ciency of placental function, rather than absence of
yolk sac circulation. Other knockouts in which lethality
vessels in the mesh of microvessels showed a range of com- of 0/0 embryos has been ascribed to placental defects die
pleteness in all genotypes. Although de®nite abnormalities between GD 10 and 10.5. For example, the mammalian
in yolk sac vacularization were not observed in 0/0 yolk achaete-scute homolog-2 0/0 embryos die from placental
sacs, a more thorough analysis would be required to elimi- failure at GD 10, apparently due to failure to establish a
nate the possibility that subtle disruptions in angiogenesis proper chorioallantoic circulation (Guillemot et al., 1994),
could be present. while most vascular cell adhesion molecule 0/0 embryos
Our observations suggest that lethality of the Arnt knock- die between GD 10 and 11, apparently either due to lack of
out is due to failure of the embryonic component of the allantoic fusion with the chorion or abnormal distribution
placenta to vascularize and form the labyrinthine spongio- of the allantoic mesoderm over the chorionic surface (Gurt-
trophoblast. De®ciency or absence of this labyrinth would ner et al., 1995).
compromise further growth and development and lead to Differences in phenotype between our knockouts and
embryonic death. those of Maltepe and co-workers may represent defects in
the same pathway which manifest at different develop-
mental stages in the two populations of mice. It is conceiv-
DISCUSSION able that the differences are attributable to differences in
genomic background, although the knockouts from both
groups were generated by intercrossing 129/Sv 1 C57BL/6Our Arnt knockout results show that the ARNT protein
serves an indispensable function in development. The criti- parental Arnt heterozygotes. (Each knockout mouse never-
theless contains a different combination of genes derivedcal events which affect survival of the embryo at GD 8.5 to
10.5 are the development of the yolk sac and chorioallantoic from the 129/Sv and C57BL/6 strains.) For example, Maltepe
and co-workers generated their knockout mice with R1 ESplacental circulations. Establishment of circulation occurs
at GD 7±8 for the yolk sac and GD 8.5±9 for the placenta. cells derived from a mating between chinchilla 129/Sv fe-
males and agouti 129/Sv-CP males, while our ES cells wereWe have shown that the allantois forms in 0/0 embryos
and makes contact with the chorionic plate and that the derived from the 129/SvJ strain of mice with a chinchilla
background. Others have reported a heterogeneity in pheno-yolk sac appears normal. However, differentiation of the
placenta fails to progress. Major defects in placental differ- types of particular knockout mice resulting from the use of
mixed genetic backgrounds (e.g., Liu et al., 1993; Dicksonentiation are incompatible with continued embryonic/fetal
growth and development, and loss of 0/0 embryos could et al., 1995). It seems unlikely that differences are the result
of the region disrupted since both knockouts were generatedbe attributed mainly to this problem. Major malformations
were often present in 0/0 embryos. The defects observed by targeting the same restriction site in the bHLH domain.
The reason for the differences among the two Arnt 0/0were severe and it would be reasonable to expect gross mor-
phological abnormalities (including exencephaly and anen- mouse lines requires further study.
It has been shown that the ARNT/HIF-1a dimer, undercephaly) if these embryos had survived to birth.
The results we describe here differ from those of another hypoxic conditions, regulates the expression of VEGF, an
inducer of angiogenesis (Wood et al., 1996). Furthermore,group that recently characterized an Arnt knockout mouse
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8758 / 6x31$$$$81 11-03-97 22:48:36 dba
303Rapid Communication
FIG. 3. (A±G) Yolk sac of GD 9.5 conceptus. (A,B) Both the /// and 0/0 yolk sac were vascularized and, in section, the blood cells are
apparent in the vessels (ARNT immunostaining with light hematoxylin counterstain). (C,D) PECAM immunostaining revealed the endothe-
lial-cell-lined vasculature (arrows) in the yolk sac of /// (C) and 0/0 (D) embryos. (E,F,G) Whole mounts of Feulgen-stained yolk sac
further illustrated the extensive, well-developed GD 9.5 vascular plexus and major vessels of 0/0 (E,G) and //0 (F) yolk sacs. (Bar: 100
mm in A±D and 500 mm in E±G; y, yolk sac; e, embryo).
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FIG. 4. (A,B) Embryonic phenotypic abnormalities. Embryonic development is similar between GD 9.5 /// and //0 embryos (A);
however, 0/0 embryos exhibited neural tube defects ranging from forebrain hypoplasia to unfused head folds, or cleft face (B). The 0/0
embryo shown in B has unfused head folds (large arrows) and diminished distance from the anterior edge of the forebrain to posterior
border of optic placode (double-headed arrows). (Bar, 100 mm).
VEGF //0 embryos exhibit signi®cant defects in the vascu- onic tissues in the differentiating placenta. On GD 9±9.5,
these cells increase in volume and our data show a promi-lature of the placenta (Ferrara et al., 1996). The VEGF tyro-
sine kinase receptors Flk-1 (VEGF-R2) and Flt-1 (VEGF-R1) nent expression of ARNT which may have functional sig-
ni®cance (Fig.2E). The phenotypic abnormalities observedare expressed in different tissues of the placenta (Breier et
al., 1995; Dumont et al., 1995). Flk-1 is localized in the in our knockout embryos either may be a consequence of
the lack of SIM1± or SIM2±ARNT dimers (or other un-labyrinthine layer of the placenta, while Flt-1 is localized
in the spongiotrophoblast layer. Flt-1 binds both VEGF and known ARNT/X dimers), since both SIM1 and SIM2 are
expressed in various tissues and organs during embryogene-placental growth factor (Maglione et al., 1991; Park et al.,
1994) and is essential for the organization of embryonic sis including the forebrain (Fan et al., 1996; Ema et al.,
1996), or may be secondary to the placental defects. Furthervasculature (Fong et al., 1995). EPAS1 (HLF) also interacts
with ARNT and is thought to be a regulator of vasculariza- analysis of the Arnt knockout mice should provide insights
into the molecular mechanisms regulating development oftion. EPAS1 can activate expression of the endothelial-spe-
ci®c tyrosine kinase receptor Tie-2 (Tek; Tian et al., 1997). the placenta and its vasculature.
The tie-2 gene is expressed in the early embryonic vascular
system, in maternal decidual vascular endothelial cells, and
in extraembryonic mesoderm cells of the amnion. A tie-2 ACKNOWLEDGMENTS
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